Petros Pharmaceuticals, Inc. (PTPI)
USD 0.06
(-7.76%)
USD 0.06
(-7.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 33.79 Million USD | 4.24% |
| 2022 | 32.42 Million USD | -51.89% |
| 2021 | 67.39 Million USD | -3.53% |
| 2020 | 69.85 Million USD | 19.68% |
| 2019 | 58.36 Million USD | -12.74% |
| 2018 | 66.88 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 25.16 Million USD | -16.97% |
| 2024 Q1 | 30.31 Million USD | -10.31% |
| 2023 Q1 | 30.57 Million USD | -5.71% |
| 2023 FY | 33.79 Million USD | 4.24% |
| 2023 Q3 | 38.91 Million USD | 35.46% |
| 2023 Q2 | 28.72 Million USD | -6.03% |
| 2023 Q4 | 33.79 Million USD | -13.15% |
| 2022 Q3 | 37.69 Million USD | -26.16% |
| 2022 Q2 | 51.04 Million USD | -8.62% |
| 2022 FY | 32.42 Million USD | -51.89% |
| 2022 Q1 | 55.86 Million USD | -17.1% |
| 2022 Q4 | 32.42 Million USD | -13.99% |
| 2021 Q1 | 66.15 Million USD | -5.3% |
| 2021 FY | 67.39 Million USD | -3.53% |
| 2021 Q4 | 67.39 Million USD | 29.51% |
| 2021 Q3 | 52.03 Million USD | -8.18% |
| 2021 Q2 | 56.67 Million USD | -14.34% |
| 2020 Q4 | 69.85 Million USD | 35.57% |
| 2020 FY | 69.85 Million USD | 19.68% |
| 2020 Q3 | 51.52 Million USD | 3.49% |
| 2020 Q2 | 49.78 Million USD | -10.31% |
| 2020 Q1 | 55.51 Million USD | -4.89% |
| 2019 Q4 | 58.36 Million USD | 0.0% |
| 2019 FY | 58.36 Million USD | -12.74% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 66.88 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | 49.023% |
| Safety Shot Inc | 12.7 Million USD | -165.916% |
| Bright Green Corporation | 17.4 Million USD | -94.195% |
| Embecta Corp. | 1.21 Billion USD | 97.217% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 96.263% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 41.141% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 97.044% |
| Dynavax Technologies Corporation | 997.09 Million USD | 96.611% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 83.578% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 95.36% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 97.853% |
| PainReform Ltd. | 9.93 Million USD | -240.34% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -23.582% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -23.582% |
| SCYNEXIS, Inc. | 128.41 Million USD | 73.682% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -46.131% |
| Journey Medical Corporation | 76.84 Million USD | 56.023% |
| Alpha Teknova, Inc. | 128.58 Million USD | 73.718% |
| Procaps Group, S.A. | 460.18 Million USD | 92.656% |
| Theratechnologies Inc. | 77.76 Million USD | 56.543% |
| Harrow Health, Inc. | 311.75 Million USD | 89.16% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -126.924% |
| Biofrontera Inc. | 27.93 Million USD | -20.993% |
| DURECT Corporation | 45.18 Million USD | 25.212% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 97.601% |
| Cronos Group Inc. | 1.13 Billion USD | 97.02% |
| OptiNose, Inc. | 107.72 Million USD | 68.629% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 92.826% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 39.595% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -46.638% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 92.653% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -183.565% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 58.673% |
| Radius Health, Inc. | 1.71 Billion USD | 98.03% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 36.578% |
| ProPhase Labs, Inc. | 91.92 Million USD | 63.236% |
| Phibro Animal Health Corporation | 982.18 Million USD | 96.559% |
| Procaps Group S.A. | 460.18 Million USD | 92.656% |
| Alvotech | 950.09 Million USD | 96.443% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 21.966% |
| Viatris Inc. | 47.68 Billion USD | 99.929% |
| Rockwell Medical, Inc. | 52.17 Million USD | 35.224% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 71.383% |
| SIGA Technologies, Inc. | 254.83 Million USD | 86.738% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.22% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 87.652% |
| Shineco, Inc. | 84.17 Million USD | 59.853% |
| PetIQ, Inc. | 868.22 Million USD | 96.107% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -300.509% |
| Incannex Healthcare Limited | 17.04 Million USD | -98.251% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 98.961% |
| Alimera Sciences, Inc. | 153.52 Million USD | 77.987% |
| Silver Spike Investment Corp. | 88.57 Million USD | 61.846% |
| Assertio Holdings, Inc. | 286.41 Million USD | 88.201% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -467.831% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -8.171% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -155.11% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 87.058% |
| Hempacco Co., Inc. | 18.04 Million USD | -87.306% |
| Talphera, Inc. | 20.39 Million USD | -65.706% |
| Alvotech | 950.09 Million USD | 96.443% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 91.679% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 97.953% |
| Currenc Group, Inc. | 141.49 Million USD | 76.114% |
| Kamada Ltd. | 351.96 Million USD | 90.398% |
| Indivior PLC | 1.95 Billion USD | 98.268% |
| Evoke Pharma, Inc. | 7.06 Million USD | -378.115% |
| Flora Growth Corp. | 23.62 Million USD | -43.045% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -155.11% |
| Evolus, Inc. | 188.99 Million USD | 82.118% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 97.359% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 97.766% |
| Akanda Corp. | 8.83 Million USD | -282.306% |